According to Karyopharm Therapeutics 's latest financial reports the company's current revenue (TTM ) is A$0.21 Billion. In 2025 the company made a revenue of A$0.21 Billion a decrease over the revenue in the year 2024 that were of A$0.23 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.